4.7 Review

Regulation of the Hippo pathway in cancer biology

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 75, Issue 13, Pages 2303-2319

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-018-2804-1

Keywords

Hippo pathway; YAP/TAZ; TEAD; Cancer; Therapeutic target

Funding

  1. Ministry of Health and Welfare, Republic of Korea [HI17C1560] Funding Source: Medline
  2. National Research Foundation of Korea [2017R1A4A1015328, 2018R1C1B6004301] Funding Source: Medline

Ask authors/readers for more resources

The Hippo tumor suppressor pathway, which is well conserved from Drosophila to humans, has emerged as the master regulator of organ size, as well as major cellular properties, such as cell proliferation, survival, stemness, and tissue homeostasis. The biological significance and deregulation of the Hippo pathway in tumorigenesis have received a surge of interest in the past decade. In the current review, we present the major discoveries that made substantial contributions to our understanding of the Hippo pathway and discuss how Hippo pathway components contribute to cellular signaling, physiology, and their potential implications in anticancer therapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available